CONGRESS ABSTRACT

Background. SGLT2-i (sodium-glucose cotrasporter-2 inhibitor) and GLP1-RA (glucagon-like peptide receptor agonist) are two new classes of glucose-lowering drugs for the treatment of diabetes mellitus. Several important randomized clinical trials demonstrated a reduction in the risk of cardiovascular events in patients with type 2 diabetes mellitus treated with SGLT2-i and GLP1-RA….

A collaborative project between the ABC Study on Heart Disease Foundation and Liceo Guglielmo Marconi. Background: Resting heart rate (RHR) is a crucial physiological parameter that reflects autonomic regulation, cardiovascular function, and overall health. In adolescents, regular physical activity, particularly sports, has been associated with improved cardiovascular efficiency, resulting…

Background: In 2022 the European Society of Cardiology published a consensus paper with six definitions of extreme cardiovascular (CV) risk. In secondary the gold standard is definition 2: two cardiovascular events within two years. Commonly used are also acute coronary syndrome (ACS) combined with peripheral or polyvascular disease (definition…

BACKGROUND. Women are generally considered at low risk for cardiovascular disease. This led to gender bias and udertreatment of female patients. Women were inadequately represented in clinical trials for a long time, so that scores used in clinical practice  may not be effective in assessing their risk. Moreover, in…

Background: cardiovascular diseases (CVDs) remain the leading global cause of morbidity and mortality, driven by risk factors such as dyslipidemia, which needs effective lipid-lowering strategies. Bempedoic acid, a novel non-statin lipid-lowering agent, acts by inhibiting ATP citrate lyase, reducing low-density lipoprotein cholesterol (LDL-C) synthesis. Many clinical trials have demonstrated its…

Background: Apulatamide, a nonsteroidal androgen receptor inhibitor, and degarelix, a gonadotrophin releasing hormone antagonist, are used as hormonal therapies for advanced prostate cancer (aPC) treatment. However, they may increase the risk of cardio-metabolic diseases which are the main cause of non-cancer-related death in patients with PC. We report a…

Background: The six-minute walk test (6MWT) reliably assesses exercise capacity of patients. Vitamin D influences muscle strength and function promoting protein synthesis and regulating calcium and phosphate levels.  Purpose: To evaluate the relationship between hypovitaminosis D levels and 6MWT results, and their prognostic significance in patients with acute myocardial infarction (AMI). …